One of the key aims of these research projects is to investigate if, and how, speakers learn to compensate for changes in speech and voice as a result of head and neck cancer. It is assumed that physiological limitations constraint certain communicative and language functions, which can impact language behaviour. All research has a clinical focus and there are strong ties between the ACLC and the Netherlands Cancer Institute-Antoni van Leeuwenhoek. There is extensive collaboration with the DSSP-ELIS at Ghent University and the Antwerp University Hospital. This research has six major branches:
In collaboration with Gent University tools are developed to automatically quantify speech intelligibility and speech quality in patients after treatment. We collaborate with Twente University in the Virtual Therapy project (www.virtualtherapy.nl). As part of this research, we investigate articulatory speech synthesis as a tool to predict speech disorders before treatment starts. The department of Head- and Neck Oncology and Surgery currently receives an unrestricted research grant from Atos Medical (Hörby, Sweden).